Skip to menu Skip to content Skip to footer
Professor Andreas Obermair
Professor

Andreas Obermair

Email: 
Phone: 
+61 7 334 66044

Overview

Background

Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and Buderim Private Hospital. He holds an Honorary title of Professor at UQ since 2006.

Professor Obermair is an internationally recognised leader in gynaecological oncology research and treatment and has lead the research team at QCGC Research since establishing it in 2003.

Availability

Professor Andreas Obermair is:
Available for supervision

Qualifications

  • Doctoral Diploma of Medicine, International University Vienna
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Research interests

  • Clinical Trials

    Decisions on cancer management ideally are based on the results of high-level evidence, obtained through clinical trials whenever possible. As a principle, a new (proposed better) intervention should be compared to the current standard treatment before being made available generally. Outside a clinical trial new treatments should not become available until evidence has become available to demonstrate superiority over the current standard treatment. Retrospective studies harbour the risk that biases influenced outcomes. At QCGC Research we engage in phase 2 and 3 clinical trials. In large phase trials, patients are allocated randomly to one of two or more interventions in order to minimise the risk of bias. Generally, patients treated within clinical trials have a better outcome compared to patients who are not treated in clinical trials. As the Director of Research Gynaecological Oncology I am currently involved in developing and managing clinical trials in gynaecological cancers.

  • Translational Research

    The focus of QCGC Research's translational research program is the application of new technology (molecular, biochemical, imaging and surgical) to prevention, detection and therapy for gynaecological cancers.

  • Quality of Life Research

    Cancer specialists are aware that not only the survival time but also the quality of life is a key factor in cancer treatment. This is especially important when two treatments are equally effective but cause different side-effects. My Quality-of-Life research focuses on ovarian, endometrial, cervical and vulval cancer. I wish to provide the best, most effective and modern treatment to my patients with least possible detriments to quality of life.

  • Minimally Invasive Surgery

    In Australia, around 30,000 hysterectomies are conducted annually to treat uterine cancer and various benign gynaecological conditions. While open abdominal surgery may be necessary in around 10% of cases, evidence shows that less-invasive approaches, such as total laparoscopic hysterectomy (TLH) can achieve better outcomes for women at a lower overall cost to the health system. Yet, in Queensland, four of ten hysterectomies are still conducted by open abdominal surgery. Our own research has shown that many Australian surgeons are keen to adopt new techniques such as TLH, but that the lack of systematic training and mentoring opportunities is the main impediment to practice-change. Together with gynaecological surgical teams at hospitals and industry support we developed a prototype for system-level transformative practice change in gynaecological surgery.

Research impacts

Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national impact of his research was recognised in 2017, when he was awarded Cancer Australia’s Jeannie Ferris Recognition Award (2017), for outstanding achievements in clinical practice and research. He is deeply engaged in consumer involvement and co-founded and serves on the Board of the Cherish Foundation, a consumer-focussed organisation that funds clinical research in better treatments for women with gynaecological cancers.

Works

Search Professor Andreas Obermair’s works on UQ eSpace

346 works between 1991 and 2024

61 - 80 of 346 works

2020

Journal Article

The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia

Caughey, Lucy, Sanjida, Saira, Obermair, Andreas and Janda, Monika (2020). The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia. Supportive Care in Cancer, 28 (11), 5479-5489. doi: 10.1007/s00520-020-05404-1

The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia

2020

Journal Article

Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study

Pigott, Amanda, Obermair, Andreas, Janda, Monika, Vagenas, Dimitrios, Ward, Leigh C., Reul-Hirche, Hildegard and Hayes, Sandra C. (2020). Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study. Gynecologic Oncology, 158 (2), 375-381. doi: 10.1016/j.ygyno.2020.04.702

Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study

2020

Journal Article

Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study

Sivakumaran, T., Mileshkin, L., Grant, P., Na, L., DeFazio, A., Friedlander, M., Obermair, A., Webb, P. M., Au-Yeung, G. and OPAL Study Group (2020). Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study. Gynecologic Oncology, 158 (1), 47-53. doi: 10.1016/j.ygyno.2020.04.706

Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study

2019

Journal Article

The impact of team familiarity on surgical outcomes in gynaecological surgery

Obermair, Andreas, Simunovic, Marko and Janda, Monika (2019). The impact of team familiarity on surgical outcomes in gynaecological surgery. Journal of Obstetrics and Gynaecology, 40 (2), 1-3. doi: 10.1080/01443615.2019.1636778

The impact of team familiarity on surgical outcomes in gynaecological surgery

2019

Journal Article

A bioimpedance spectroscopy-based method for diagnosis of lower-limb lymphedema

Steele, Megan L., Janda, Monika, Vagenas, Dimitrios, Ward, Leigh C., Cornish, Bruce H., Box, Robyn, Gordon, Susan, Matthews, Melanie, Poppitt, Sally D., Plank, Lindsay D., Yip, Wilson, Rowan, Angela, Reul-Hirche, Hildegard, Obermair, Andreas and Hayes, Sandra C. (2019). A bioimpedance spectroscopy-based method for diagnosis of lower-limb lymphedema. Lymphatic Research and Biology, 18 (2) lrb.2018.0078, 101-109. doi: 10.1089/lrb.2018.0078

A bioimpedance spectroscopy-based method for diagnosis of lower-limb lymphedema

2019

Journal Article

How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial

Obermair, Andreas, Armfield, Nigel R., Graves, Nicholas, Gebski, Val, Hanna, George B., Coleman, Mark G, Hughes, Anne and Janda, Monika (2019). How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial. BMJ Open, 9 (5) e027155, e027155. doi: 10.1136/bmjopen-2018-027155

How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial

2019

Journal Article

Patient-reported experiences after hysterectomy: A cross-sectional study of the views of over 2300 women

Janda, Monika, Armfield, Nigel R, Kerr, Gayle, Kurz, Suzanne, Jackson, Graeme, Currie, Jason, Page, Katie, Weaver, Edward, Yazdani, Anusch and Obermair, Andreas (2019). Patient-reported experiences after hysterectomy: A cross-sectional study of the views of over 2300 women. Journal of Patient Experience, 7 (3), 237437351984007-379. doi: 10.1177/2374373519840076

Patient-reported experiences after hysterectomy: A cross-sectional study of the views of over 2300 women

2019

Journal Article

Incidence of adverse events, preventability and mortality in gynaecological hospital admissions: a systematic review and meta-analysis

Tanaka, Keisuke, Eriksson, Lars, Asher, Rebecca and Obermair, Andreas (2019). Incidence of adverse events, preventability and mortality in gynaecological hospital admissions: a systematic review and meta-analysis. Australian and New Zealand Journal of Obstetrics and Gynaecology, 59 (2), 195-200. doi: 10.1111/ajo.12937

Incidence of adverse events, preventability and mortality in gynaecological hospital admissions: a systematic review and meta-analysis

2019

Journal Article

How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?

Sanjida, Saira, Janda, Monika, McPhail, Steven M., Kissane, David, Couper, Jeremy, Scott, James and Obermair, Andreas (2019). How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?. Gynecologic Oncology, 152 (2), 339-345. doi: 10.1016/j.ygyno.2018.11.018

How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?

2019

Conference Publication

Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial

Obermair, Andreas, Asher, Rebecca, Pareja, Rene, Frumovitz, Michael, Lopez, Aldo, Moretti-Marques, Renato, Rendon, Gabriel, Ribeiro, Reitan, Tsunoda, Audrey, Behan, Vanessa, Buda, Alessandro, Bernadini, Marcus Q., Zhao, Hongqin, Vieira, Marcelo, Walker, Joan, Spirtos, Nick M., Yao, Shuzhong, Chetty, Naven, Zhu, Tao, Isla, David, Tamura, Mariano, Nicklin, James, Robledo, Kristy P., Gebski, Val, Coleman, Robert L., Salvo, Gloria and Ramirez, Pedro T. (2019). Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Biennial Meeting of the International Gynecologic Cancer Society (IGCS), Kyoto, Japan, 14-16 September 2018. Philadelphia, PA, United States: Mosby. doi: 10.1016/j.ajog.2019.09.036

Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial

2019

Conference Publication

Weight perception and sociodemographic characteristics following endometrial cancer treatment

Janda, M., Gebski, V., Forder, P. and Obermair, A. (2019). Weight perception and sociodemographic characteristics following endometrial cancer treatment. 2019 IGCS Annual Global Meeting, Rio de Janeiro, Brazil, 19 – 21 September, 2019. London, United Kingdom: B M J Group. doi: 10.1136/ijgc-2019-IGCS.57

Weight perception and sociodemographic characteristics following endometrial cancer treatment

2019

Conference Publication

The implementation of a standardized surgical training program for specialist gynaecologists to decrease the rate of open, abdominal hysterectomy

Janda, M. and Obermair, A. (2019). The implementation of a standardized surgical training program for specialist gynaecologists to decrease the rate of open, abdominal hysterectomy. 2019 IGCS Annual Global Meeting, Rio de Janeiro, Brazil, 19 – 21 September, 2019. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2019-IGCS.53

The implementation of a standardized surgical training program for specialist gynaecologists to decrease the rate of open, abdominal hysterectomy

2018

Journal Article

Normative interlimb impedance ratios: implications for early diagnosis of uni- and bilateral, upper and lower limb lymphedema

Steele, Megan L., Janda, Monika, Vagenas, Dimitrios, Ward, Leigh C., Cornish, Bruce H., Box, Robyn, Gordon, Susan, Matthews, Melanie, Poppitt, Sally D., Plank, Lindsay D., Yip, Wilson, Rowan, Angela, Reul-Hirche, Hildegard, Obermair, Andreas and Hayes, Sandra C. (2018). Normative interlimb impedance ratios: implications for early diagnosis of uni- and bilateral, upper and lower limb lymphedema. Lymphatic Research and Biology, 16 (6), 559-566. doi: 10.1089/lrb.2017.0082

Normative interlimb impedance ratios: implications for early diagnosis of uni- and bilateral, upper and lower limb lymphedema

2018

Journal Article

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

Ramirez, Pedro T., Frumovitz, Michael, Pareja, Rene, Lopez, Aldo, Vieira, Marcelo, Ribeiro, Reitan, Buda, Alessandro, Yan, Xiaojian, Yao Shuzhong,, Chetty, Naven, Isla, David, Tamura, Mariano, Zhu, Tao, Robledo, Kristy P., Gebski, Val, Asher, Rebecca, Behan, Vanessa, Nicklin, James L., Coleman, Robert L. and Obermair, Andreas (2018). Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. New England Journal of Medicine, 379 (20), 1895-1904. doi: 10.1056/NEJMoa1806395

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

2018

Conference Publication

Quality of life assessment in early-stage cervical cancer patients in undergoing radical hysterectomy via minimally invasive surgery or open approach: The LACC Trial

Frumovitz, M., Obermair, A., Pareja, R., Lopez, A., de Andrade Vieira, M., Ribeiro, R., Buda, A., Yan, X., Robledo, K., Asher, R., Gebski, V., Behan, V., Coleman, R. and Ramirez, P. (2018). Quality of life assessment in early-stage cervical cancer patients in undergoing radical hysterectomy via minimally invasive surgery or open approach: The LACC Trial. _, _, _. London, United Kingdom: BMJ Group.

Quality of life assessment in early-stage cervical cancer patients in undergoing radical hysterectomy via minimally invasive surgery or open approach: The LACC Trial

2018

Conference Publication

Incidence of adverse events comparing abdominal vs. minimally invasive radical hysterectomy in patients with early-stage cervical cancer: LACC Trial

Obermair, A., Asher, R., Frumovitz, M., Pareja, R., Lopez, A., Viera, M., Ribeiro, R., Buda, A., Yan, X., Robledo, K. P., Gebski, V., Coleman, R. L. and Ramirez, P. T. (2018). Incidence of adverse events comparing abdominal vs. minimally invasive radical hysterectomy in patients with early-stage cervical cancer: LACC Trial. _, _, _. London, United Kingdom: BMJ Group.

Incidence of adverse events comparing abdominal vs. minimally invasive radical hysterectomy in patients with early-stage cervical cancer: LACC Trial

2018

Journal Article

Challenges and controversies in the conservative management of uterine and ovarian cancer

Janda, M., McGrath, S. and Obermair, A. (2018). Challenges and controversies in the conservative management of uterine and ovarian cancer. Best Practice and Research: Clinical Obstetrics and Gynaecology, 55, 93-108. doi: 10.1016/j.bpobgyn.2018.08.004

Challenges and controversies in the conservative management of uterine and ovarian cancer

2018

Journal Article

Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use

Armfield, N. R., Janda, M. and Obermair, A. (2018). Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use. International Journal for Quality in Health Care, 31 (4), 283-288. doi: 10.1093/intqhc/mzy162

Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use

2018

Journal Article

All-cause death in young women with endometrial cancer who receive progesterone therapy

Obermair, Andreas, Janda, Monika and Gebski, Val (2018). All-cause death in young women with endometrial cancer who receive progesterone therapy. American Journal of Obstetrics and Gynecology, 219 (1), 119-119. doi: 10.1016/j.ajog.2018.03.009

All-cause death in young women with endometrial cancer who receive progesterone therapy

2018

Journal Article

Surgical approach to hysterectomy and barriers to using minimally invasive methods

Janda, Monika, Armfield, Nigel R., Kerr, Gayle, Kurz, Suzanne, Jackson, Graeme, Currie, Jason, Page, Katie, Weaver, Edward, Yazdani, Anusch and Obermair, Andreas (2018). Surgical approach to hysterectomy and barriers to using minimally invasive methods. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 58 (6), 690-695. doi: 10.1111/ajo.12824

Surgical approach to hysterectomy and barriers to using minimally invasive methods

Funding

Current funding

  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2024 - 2025
    Queensland Centre for Gynaecological Cancer's NODE Study
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2024 - 2028
    ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2025
    Feasibility testing Of telehealth-delivered eXercise Therapy for Ostomates Treated for cancer (FOXTROT)
    Wesley Research Institute Ltd
    Open grant
  • 2023 - 2028
    Vulvar Cancer Feasibility Study: Establishing a novel pathway to best-practice treatment in vulvar cancer
    Research Donation Generic
    Open grant
  • 2022 - 2025
    A non-surgical alternative to hysterectomy for the treatment of endometrial cancer
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2025
    Creating treatment options for endometrial cancer through high-level clinical trials
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2024
    A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith).
    Griffith University
    Open grant
  • 2010 - 2024
    QCOG (Data Manager Grant)
    Cancer Council Queensland
    Open grant

Past funding

  • 2024
    Moving without fear when living with stoma: A consumer-led physical activity study
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2021 - 2024
    MOST (Measure of Ovarian Symptoms and Treatment concerns)
    St John of God Healthcare Inc
    Open grant
  • 2020 - 2022
    A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial)
    Cherish Women's Cancer Foundation
    Open grant
  • 2020 - 2023
    Implementing non-surgical options for endometrial cancer treatment into clinical practice
    ICON Cancer Care
    Open grant
  • 2020 - 2021
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2020
    feMMe Long Term Follow-Up study
    ASGO Research Grants
    Open grant
  • 2019 - 2020
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2017 - 2020
    The Implementation of MinimAlly INvasivE hysterectomy (IMAGINE) trial
    NHMRC Partnership Projects
    Open grant
  • 2017 - 2018
    Transforming surgical practice through innovation IMAGINE
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2021
    The ECHO trial: Exercise during CHemotherapy for Ovarian cancer (World Cancer Research Fund International grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2021
    The Ovarian Cancer Prognosis and Lifestyle (OPAL) Study: Long-term outcomes (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2018
    Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial - survival outcomes
    Cancer Australia
    Open grant
  • 2016
    QCOG 2016
    Cancer Council Queensland
    Open grant
  • 2015 - 2019
    Cherish women's cancer foundation research fellow funding
    Cherish Women's Cancer Foundation
    Open grant
  • 2015 - 2022
    ECHO trial: Exercise during Chemotherapy for Ovarian cancer (Cancer Australia grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2018
    The fEMMe trial
    Cancer Australia
    Open grant
  • 2015 - 2016
    In Memory of Denise Marcella Collins
    Research Donation Generic
    Open grant
  • 2015 - 2016
    Impact of gated PET/CT on the diagnosis of distant metastases of advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2015 - 2019
    Selective targeting of adjuvant therapy for endometrial cancer: the STATEC trial (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2015
    Barriers of the uptake of laparoscopic hysterectomy
    Australian Centre for Health Services Innovation
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2014 - 2015
    Prophylactic surgery and breast cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2013 - 2020
    ACRF Molecular Oncology Translational Imaging Facility (MOTIF)
    Australian Cancer Research Foundation
    Open grant
  • 2013 - 2016
    Mirena ±Weight Loss to treat early Endometrial Cancer (MAxWEL Trial - Cancer Australia grant administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2013
    A phase II randomised clinical trial of mirena +/- metformin in patients with early stage cancer of the endometrium
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013
    QCOG 2013 (Data Manager Grants)
    Cancer Council Queensland
    Open grant
  • 2012 - 2023
    In Memory of Jan Sanders and other philanthropic donations
    Research Donation Generic
    Open grant
  • 2012 - 2013
    LEGS follow-up: Lymphoedema Evaluation following Gynaecology Cancer Study
    Queensland University of Technology
    Open grant
  • 2012 - 2013
    The effect of prophylactic, risk-reducing gynaecological surgery on survival among patients with a history of breast cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    HE 4 Collaborative Study
    Abbott Australasia Pty Ltd
    Open grant
  • 2011
    LEGS:Lymphoedema Evaluation in Gynaecological Cancer Study
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Wesley Merdical Research
    Open grant
  • 2010 - 2023
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal radical hysterectomy in patients with early stage cervical cancer (Clinical Trial Agreement)
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2010 - 2013
    Laparoscopic Approach to Carcinoma of the Endometrium. An international multicentre randomised Phase 3 clinical trial
    Cancer Australia
    Open grant
  • 2010 - 2013
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Cancer Australia
    Open grant
  • 2009 - 2011
    National Gynaecological Cancers Service Delivery and Resources Framework
    Cancer Australia
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Research & development into better standard of care for women experiencing gynaecological cancer
    Mayne Bequest Fund
    Open grant
  • 2009 - 2012
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2009 - 2010
    Cancer Clinical Trial Data Management Grant 2009
    Cancer Council Queensland
    Open grant
  • 2009 - 2010
    Post-operative enteral nutrition among patients with ovarian cancer
    Gallipoli Research Foundation
    Open grant
  • 2009
    Prognostic value of preoperative CA125 in ovarian tumours of low malignant potential
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2009 - 2010
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Gallipoli Research Foundation
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Wesley Merdical Research
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Cancer Australia
    Open grant
  • 2008 - 2009
    LACE - Laparoscopic Approach to Carcinoma of the Endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2008
    Cancer Clinical Trial Data Management grant 2008
    Queensland Cancer Fund
    Open grant
  • 2008
    Laparoscopic approach to cervical carcinoma -a phase III randomised clinical trial of laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients w/ early stage cervical cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic hysterectomy for Endometrial Cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007
    Cancer Clinical Trial Data Manager, QLD Centre for Gynaecological cancer - 2007
    Queensland Cancer Fund
    Open grant
  • 2007
    LACE- Laparoscopic approach to carcinoma of the endometrium - An international multicentre randomised phase 3 clinical trial - Top-Up funding
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer
    NHMRC Project Grant
    Open grant
  • 2006
    Cancer Clinical Trial Data Manager at the QLD Centre for Gynaecological Cancer
    Queensland Cancer Fund
    Open grant
  • 2006
    LACE - Laparoscopic approach to carinoma of the endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Queensland Cancer Fund
    Open grant
  • 2006 - 2007
    Total laparoscopic hysterectomy (TLH) vs Total Abdominal Hysterectomy (TAH) for the treatment of endometrial cancer
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Clinical Trial Data Manager
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Start-up Grant
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2004 - 2007
    Gynaecological Cancer Society Research Grants
    Gynaecological Cancer Society
    Open grant
  • 2004
    Mismatch repair gene defects in endometrial cancer patients less than 50 years of age
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant

Supervision

Availability

Professor Andreas Obermair is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • feMMe: Uterus-preserving treatment of endometrial cancer

    In 2020 we completed the feMMe, phase 2 cliniccal trial which established anticancer activity of levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps towards estabnlioshing this treatment for larger groups of patients include:

    1. To determine factors that predict response to LNG-IUD

    2. To determine long-term patient outcomes including survival, fertility, and patient needs.

  • Improving Quality of Survival for Women with Gynaecological Cancer

    • Focus on improving quality of life, health & function during & after gynaecological cancer treatment, with a focus on biomarker research, implementation research and cancer survivorship.

Supervision history

Current supervision

  • Doctor Philosophy

    Diet quality and composition in Australian women with endometrial cancer

    Associate Advisor

    Other advisors: Professor Monika Janda

Completed supervision

Media

Enquiries

For media enquiries about Professor Andreas Obermair's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au